Bayer Crop Science

Bayer Crop Science takes the top position in this category on the strength of a seed and traits business placed at US$11.2-14.8 billion, the largest seed revenue base in this field, supported by more than 500 new hybrid varieties a year and seed operations in over 140 countries. It leads despite carrying the heaviest legal load in the set, with about EUR 981 million of special litigation charges in 2025 and a seven-year antitrust commitment on how it bundles corn and soybean seed. The 89/100 score records that trade-off: unmatched commercial reach and breeding capacity, discounted for litigation and regulatory constraint.

Industry Position

Within plant propagation materials, Bayer Crop Science is the largest single manufacturer by seed and traits revenue, and the position is built on row crops rather than vegetables - DEKALB hybrid corn, Asgrow soybeans and Stoneville cotton stand alongside InVigor canola and the Seminis and De Ruiter vegetable lines. Crop Science revenue reached EUR 21.6 billion in 2025, of which seeds and traits accounted for US$11.2-14.8 billion. That split defines the business: it is not a pure seed house, and close to half its revenue comes from crop protection chemistry sold to the same growers.

Geographic balance reinforces the position. Seed operations reach more than 140 countries, and the fourth quarter of 2025 was decided in the Americas, where corn seed and traits delivered price and acreage gains above expectations and quarterly Crop Science revenue reached EUR 11.44 billion. Because the parent Bayer AG is ranked 301st on the 2025 Fortune Global 500 with US$50,401.2 million of revenue while the division is not a member, this placement rests entirely on segment-level numbers rather than group scale.

Competitive Advantages

The breeding engine comes first: more than 500 new hybrid varieties released each year, supported by over 150 seed conditioning and coating plants and breeding stations. Variety turnover at that rate keeps a corn, soybean and cotton portfolio defensible as disease pressure and growing regions shift, and the conditioning plants convert the output into treated, graded, pelletised seed near the markets that buy it.

The second advantage is the data and services layer. FieldView passes 250 million subscribed acres, so the division reaches the same fields with digital agronomy that it supplies with genetics and chemistry. Bundling genetics, traits, treatment and advice through the Premier Performance programme has been commercially effective - precisely why the US Department of Justice scrutinised it - and it creates a switching cost for large growers that a genetics-only rival cannot match.

Strategic Expansion

Product expansion runs toward stress tolerance and crop architecture rather than new chemistry. Preceon, the short-stature corn system, is being pushed into North America on the argument that a shorter plant resists lodging and can be managed more intensively, while the newgold brand, launched in February 2026, moves the seed business into biofuel feedstock crops. Both extend the portfolio into adjacent demand.

Inside research, the division added early screening of new compounds for pollinator insect toxicity to its 2026 pipeline work, a compliance-driven step that also shapes what can be sold in the European Union. Organisationally, the Dynamic Shared Ownership model is rolling out against a target of about EUR 2 billion in structural cost savings by the end of 2026 - a programme reaching far beyond crop science, given the group's 88,078 employees.

Risks & Outlook

Litigation is the dominant risk. Glyphosate claims and legacy PCB cases remain open, and Bayer booked roughly EUR 981 million of special litigation charges in 2025 alone. Charges at that level move group earnings independently of how the seed business trades, and no pricing decision inside the division can offset them.

Regulatory limits on bundling are the second risk. Under the US Department of Justice antitrust review, Bayer removed the corn and soybean tying clauses from its Premier Performance loyalty programme and committed to maintain that for seven years, capping the leverage its trait stack once gave it over dealer and grower purchasing. Add the execution cost of the reorganisation and the picture is a division with strong commercial momentum and an unusually heavy non-operating load. VerityRank Score of 89/100.